section name header

Pronunciation

dye-peer-ID-a-mole audio

Indications

BEERS REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Moderately absorbed (30–60%) after oral administration.

Distribution: Widely distributed. Crosses the placenta; enters breast milk.

Metabolism/Excretion: Metabolized by the liver; excreted in the bile.

Half-life: 10 hr.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Neuro: dizziness, headache, syncope.
IV only: transient cerebral ischemia, weakness.

Resp: IV only: bronchospasm.

CV: IV only: MI, hypotension, arrhythmias, flushing.

GI: nausea, diarrhea, GI upset, vomiting.

Derm: rash.

Interactions

Drug-Drug:

Route/Dosage

see Calculator

Implementation

US Brand Names

Persantine

Canadian Brand Names

Persantine

Classifications

Therapeutic Classification: antiplatelet agents, diagnostic agents (coronary vasodilators)

Pharmacologic Classification: platelet adhesion inhibitors

Availability

(Generic available)

Time/Action Profile

(PO = antiplatelet activity, IV = coronary vasodilation)

ROUTEONSETPEAKDURATION
POunknownunknownunknown
IVunknown6.5 min30 min

†From start of infusion.

Assessment

Lab Test Considerations:

Pot. Nursing Diagnoses

Patient/Family Teaching

Evaluation/Desired Outcomes

Code

NDC Code*